Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neoplasms × Phototherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Mycosis Fungoides 5 Squamous Cell Carcinoma of Head and Neck 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Liver Neoplasms 2 Keratosis, Actinic 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Tongue Neoplasms 1 Stomach Neoplasms 1 Sleep Wake Disorders 1 Pleural Diseases 1 Peptic Ulcer 1 Neoplasms 1 Mesothelioma, Malignant 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma 1 Lymphoid Interstitial Pneumonia 1 Hematologic Neoplasms 1 Gallbladder Neoplasms 1 Fatigue 1 Bile Duct Neoplasms 1

Interventions

pembrolizumab 150 Gemcitabine 140 Paclitaxel 128 Carboplatin 116 Bevacizumab 110 Cyclophosphamide 97 Docetaxel 95 Cisplatin 95 Nivolumab 79 Exercise 79 Capecitabine 76 Fluorouracil 74 Dexamethasone 71 Irinotecan 64 Radiotherapy 58 Oxaliplatin 58 Pemetrexed 57 Standard of Care 55 Leucovorin 53 Cetuximab 48 Drug Therapy 47 Sorafenib 45 Erlotinib Hydrochloride 44 Blood Specimen Collection 44 Doxorubicin 43 atezolizumab 40 130-nm albumin-bound paclitaxel 38 trametinib 35 fludarabine 34 Methods 34

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02879864 2023-12-15

EFFLUX

Fondation Hôpital Saint-Joseph

Phase NA Unknown

Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡